ID16420A - Komposisi farmasi baru dengan efek anastesia - Google Patents
Komposisi farmasi baru dengan efek anastesiaInfo
- Publication number
- ID16420A ID16420A IDP971235A ID971235A ID16420A ID 16420 A ID16420 A ID 16420A ID P971235 A IDP971235 A ID P971235A ID 971235 A ID971235 A ID 971235A ID 16420 A ID16420 A ID 16420A
- Authority
- ID
- Indonesia
- Prior art keywords
- anastesia
- effects
- pharmaceutical composition
- new pharmaceutical
- new
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A61P23/02—Local anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Anesthesiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9601421A SE9601421D0 (sv) | 1996-04-12 | 1996-04-12 | New composition |
Publications (1)
Publication Number | Publication Date |
---|---|
ID16420A true ID16420A (id) | 1997-09-25 |
Family
ID=20402194
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IDP971235A ID16420A (id) | 1996-04-12 | 1997-04-14 | Komposisi farmasi baru dengan efek anastesia |
Country Status (30)
Country | Link |
---|---|
US (1) | US6031007A (fr) |
EP (1) | EP0833612B1 (fr) |
JP (2) | JPH11501678A (fr) |
KR (1) | KR100508601B1 (fr) |
CN (1) | CN1149072C (fr) |
AR (1) | AR006484A1 (fr) |
AT (1) | ATE248584T1 (fr) |
AU (1) | AU716540B2 (fr) |
BR (1) | BR9702147A (fr) |
CA (1) | CA2222676C (fr) |
CZ (1) | CZ371197A3 (fr) |
DE (1) | DE69724545T2 (fr) |
DK (1) | DK0833612T3 (fr) |
EE (1) | EE9700363A (fr) |
ES (1) | ES2203799T3 (fr) |
HK (1) | HK1010144A1 (fr) |
HU (1) | HUP9903544A3 (fr) |
ID (1) | ID16420A (fr) |
IL (1) | IL122447A (fr) |
IS (1) | IS4618A (fr) |
NO (1) | NO318239B1 (fr) |
NZ (1) | NZ329246A (fr) |
PL (1) | PL324170A1 (fr) |
RU (1) | RU2185153C2 (fr) |
SE (1) | SE9601421D0 (fr) |
SK (1) | SK169897A3 (fr) |
TR (1) | TR199701584T1 (fr) |
TW (1) | TW473386B (fr) |
WO (1) | WO1997038675A1 (fr) |
ZA (1) | ZA973022B (fr) |
Families Citing this family (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2764800B1 (fr) * | 1997-06-23 | 1999-09-10 | Sanofi Sa | Composition pharmaceutique solide contenant des derives de benzofuranne |
US7799337B2 (en) | 1997-07-21 | 2010-09-21 | Levin Bruce H | Method for directed intranasal administration of a composition |
CN1221249C (zh) * | 1998-08-19 | 2005-10-05 | 斯凯伊药品加拿大公司 | 普鲁泊福的可注射水分散体 |
US6528086B2 (en) * | 1999-09-28 | 2003-03-04 | Zars, Inc. | Methods and apparatus for drug delivery involving phase changing formulations |
US20020013331A1 (en) * | 2000-06-26 | 2002-01-31 | Williams Robert O. | Methods and compositions for treating pain of the mucous membrane |
KR100416646B1 (ko) * | 2000-08-14 | 2004-02-05 | 구주제약주식회사 | 리도카인을 함유한 조루치료용 마이크로에멀젼 하이드로겔 제형의 약학 조성물 |
GB0120701D0 (en) | 2001-08-24 | 2001-10-17 | Maelor Pharmaceuticals Ltd | Pharmaceutical formulations |
US20040087520A1 (en) * | 2002-10-25 | 2004-05-06 | Chowdhury Dipak K. | Compositions and methods for delivery of therapeutic agents |
TW200410717A (en) * | 2002-12-31 | 2004-07-01 | Ind Tech Res Inst | Delivery system for control release of temperature sensitive bioactive material |
AU2003900887A0 (en) * | 2003-02-27 | 2003-03-13 | Novasel Australia Pty Ltd | Poloxamer emulsion preparations |
US8802116B2 (en) | 2003-02-27 | 2014-08-12 | Novasel Australia Pty. Ltd. | Poloxamer emulsion preparations |
BR0301968A (pt) * | 2003-05-22 | 2005-06-28 | Cristalia Prod Quimicos Farm | Misturas eutéticas ternárias e quaternárias constituìdas por substâncias anestésicas locais, seu emprego no preparo de composições farmacêuticas e seu uso em anestesia e analgesia tópica |
JP4669960B2 (ja) * | 2003-06-03 | 2011-04-13 | 株式会社 メドレックス | 局所麻酔薬を含有する口中用または咽頭部用製剤 |
US7943179B2 (en) * | 2003-09-23 | 2011-05-17 | Massachusetts Institute Of Technology | pH triggerable polymeric particles |
US20050123596A1 (en) * | 2003-09-23 | 2005-06-09 | Kohane Daniel S. | pH-triggered microparticles |
US20070232695A1 (en) * | 2004-01-28 | 2007-10-04 | Collegium Pharmaceutical, Inc. | Gelled Periodontal Anesthetic Preparation |
US8907153B2 (en) | 2004-06-07 | 2014-12-09 | Nuvo Research Inc. | Adhesive peel-forming formulations for dermal delivery of drugs and methods of using the same |
US8741332B2 (en) | 2004-06-07 | 2014-06-03 | Nuvo Research Inc. | Compositions and methods for dermally treating neuropathic pain |
US8741333B2 (en) | 2004-06-07 | 2014-06-03 | Nuvo Research Inc. | Compositions and methods for treating dermatitis or psoriasis |
WO2006037047A2 (fr) * | 2004-09-27 | 2006-04-06 | Bridge Pharma, Inc. | R-isomere de 2-{2-[n-(2-indanyl)-n-phenylamino]ethyl}piperidine et autres agents anesthesiques dermiques |
US7718674B2 (en) * | 2004-09-27 | 2010-05-18 | Bridge Pharma, Inc. | Methods of relieving neuropathic pain with the S-isomer of 2-{2[N-(2-indanyl)-N-phenylamino]ethyl}piperidine |
US7592458B2 (en) * | 2006-07-21 | 2009-09-22 | Wright George E | Dermal anesthetic compounds and pharmaceutical compositions for inducing local anesthesia and mitigating neuropathic pain |
US20090123527A1 (en) * | 2006-07-24 | 2009-05-14 | Akorn, Inc. | Method of inducing topical anesthesia and transdermal patch |
US20080021068A1 (en) | 2006-07-24 | 2008-01-24 | Akorn, Inc. | Aqueous gel formulation and method for inducing topical anesthesia |
US8473062B2 (en) | 2008-05-01 | 2013-06-25 | Autonomic Technologies, Inc. | Method and device for the treatment of headache |
US8412336B2 (en) | 2008-12-29 | 2013-04-02 | Autonomic Technologies, Inc. | Integrated delivery and visualization tool for a neuromodulation system |
US9012477B2 (en) | 2009-01-06 | 2015-04-21 | Nuvo Research Inc. | Method of treating neuropathic pain |
US8494641B2 (en) | 2009-04-22 | 2013-07-23 | Autonomic Technologies, Inc. | Implantable neurostimulator with integral hermetic electronic enclosure, circuit substrate, monolithic feed-through, lead assembly and anchoring mechanism |
US9320908B2 (en) | 2009-01-15 | 2016-04-26 | Autonomic Technologies, Inc. | Approval per use implanted neurostimulator |
US20130045238A1 (en) * | 2009-04-22 | 2013-02-21 | Agency For Science, Technology And Research | Emulsions for transdermal delivery |
WO2011074015A2 (fr) | 2009-12-17 | 2011-06-23 | Themis Medicare Limited | Nouvelle composition de produit pharmaceutique destinée à traiter un dysfonctionnement sexuel |
WO2011088333A2 (fr) | 2010-01-14 | 2011-07-21 | Zars Pharma, Inc. | Formulations pour anesthésie locale se solidifiant pour la gestion de la douleur |
MX2012011262A (es) * | 2010-04-01 | 2013-02-11 | Pharmanest Ab | Composiciones anestesicas termogelificantes. |
WO2011121034A2 (fr) | 2010-04-01 | 2011-10-06 | Pharmanest Ab | Compositions pharmaceutiques sans eau appropriées à des anesthésiques locaux |
EA201290790A1 (ru) | 2010-04-01 | 2013-04-30 | Фарманест Аб | Биоадгезивные композиции местных анестетиков |
WO2011133177A1 (fr) * | 2010-04-21 | 2011-10-27 | Teikoku Pharma Usa, Inc. | Compositions pour émulsions à effet anésthésique local, procédés de fabrication et procédés d'utilisation |
GB201222455D0 (en) * | 2012-12-13 | 2013-01-30 | Perioc Ltd | Novel pharmaceutical formulations and their use in the treatment of periodontaldisease |
CA2914608A1 (fr) * | 2013-03-14 | 2014-09-25 | Jsn I, Llc | Masquage du gout d'anesthesiques et d'analgesiques |
WO2017039559A1 (fr) | 2015-09-02 | 2017-03-09 | T.C. Istanbul Medipol Universitesi | Formulations d'hydrogels à base de micro-émulsion chargée de benzocaïne à des fins thérapeutiques et leur procédé de production |
WO2020182535A1 (fr) | 2019-03-08 | 2020-09-17 | Bayer Oy | Tube de sonde utérine ayant un applicateur d'anesthésique |
CN113244167B (zh) * | 2021-05-20 | 2022-11-29 | 河北科技大学 | 一种盐酸利多卡因凝胶及其制备方法 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4188373A (en) * | 1976-02-26 | 1980-02-12 | Cooper Laboratories, Inc. | Clear, water-miscible, liquid pharmaceutical vehicles and compositions which gel at body temperature for drug delivery to mucous membranes |
US4478822A (en) * | 1983-05-16 | 1984-10-23 | Merck & Co., Inc. | Drug delivery system utilizing thermosetting gels |
US5288498A (en) * | 1985-05-01 | 1994-02-22 | University Of Utah Research Foundation | Compositions of oral nondissolvable matrixes for transmucosal administration of medicaments |
US5288497A (en) * | 1985-05-01 | 1994-02-22 | The University Of Utah | Compositions of oral dissolvable medicaments |
JPS62223112A (ja) * | 1986-03-25 | 1987-10-01 | Rooto Seiyaku Kk | 歯周病治療剤 |
US4780320A (en) * | 1986-04-29 | 1988-10-25 | Pharmetrix Corp. | Controlled release drug delivery system for the periodontal pocket |
US5114719A (en) * | 1987-04-29 | 1992-05-19 | Sabel Bernhard A | Extended drug delivery of small, water-soluble molecules |
US5411738A (en) * | 1989-03-17 | 1995-05-02 | Hind Health Care, Inc. | Method for treating nerve injury pain associated with shingles (herpes-zoster and post-herpetic neuralgia) by topical application of lidocaine |
CA2040460C (fr) * | 1990-05-01 | 1997-06-10 | Tacey X. Viegas | Distribution de medicaments au moyen de gels thermoreversibles |
US5292516A (en) * | 1990-05-01 | 1994-03-08 | Mediventures, Inc. | Body cavity drug delivery with thermoreversible gels containing polyoxyalkylene copolymers |
FR2704429B3 (fr) * | 1993-04-30 | 1995-07-13 | Algovital Sarl | Formulation associant une réaction alcaline et des composants d'huiles essentielles pour réaliser une anesthésie locale, par voie externe, transcutanée, sans injection. |
US5635540A (en) * | 1994-12-09 | 1997-06-03 | The University Of Virginia Patent Foundation | Stabilized topical pharmaceutical preparations |
US5612052A (en) * | 1995-04-13 | 1997-03-18 | Poly-Med, Inc. | Hydrogel-forming, self-solvating absorbable polyester copolymers, and methods for use thereof |
-
1996
- 1996-04-12 SE SE9601421A patent/SE9601421D0/xx unknown
-
1997
- 1997-03-31 TW TW086104109A patent/TW473386B/zh not_active IP Right Cessation
- 1997-04-01 AT AT97919826T patent/ATE248584T1/de not_active IP Right Cessation
- 1997-04-01 DK DK97919826T patent/DK0833612T3/da active
- 1997-04-01 SK SK1698-97A patent/SK169897A3/sk unknown
- 1997-04-01 EP EP97919826A patent/EP0833612B1/fr not_active Expired - Lifetime
- 1997-04-01 EE EE9700363A patent/EE9700363A/xx unknown
- 1997-04-01 US US08/875,888 patent/US6031007A/en not_active Expired - Lifetime
- 1997-04-01 HU HU9903544A patent/HUP9903544A3/hu unknown
- 1997-04-01 CN CNB971903425A patent/CN1149072C/zh not_active Expired - Lifetime
- 1997-04-01 PL PL97324170A patent/PL324170A1/xx unknown
- 1997-04-01 ES ES97919826T patent/ES2203799T3/es not_active Expired - Lifetime
- 1997-04-01 KR KR1019970709302A patent/KR100508601B1/ko not_active IP Right Cessation
- 1997-04-01 AU AU24168/97A patent/AU716540B2/en not_active Expired
- 1997-04-01 CZ CZ973711A patent/CZ371197A3/cs unknown
- 1997-04-01 WO PCT/SE1997/000566 patent/WO1997038675A1/fr active IP Right Grant
- 1997-04-01 NZ NZ329246A patent/NZ329246A/en not_active IP Right Cessation
- 1997-04-01 BR BR9702147A patent/BR9702147A/pt not_active Application Discontinuation
- 1997-04-01 TR TR97/01584T patent/TR199701584T1/xx unknown
- 1997-04-01 DE DE69724545T patent/DE69724545T2/de not_active Expired - Lifetime
- 1997-04-01 JP JP9537002A patent/JPH11501678A/ja not_active Withdrawn
- 1997-04-01 RU RU98100471/14A patent/RU2185153C2/ru active
- 1997-04-01 IL IL12244797A patent/IL122447A/en not_active IP Right Cessation
- 1997-04-01 CA CA002222676A patent/CA2222676C/fr not_active Expired - Lifetime
- 1997-04-02 AR ARP970101317A patent/AR006484A1/es active IP Right Grant
- 1997-04-09 ZA ZA9703022A patent/ZA973022B/xx unknown
- 1997-04-14 ID IDP971235A patent/ID16420A/id unknown
- 1997-11-21 IS IS4618A patent/IS4618A/is unknown
- 1997-12-11 NO NO19975831A patent/NO318239B1/no not_active IP Right Cessation
-
1998
- 1998-10-05 HK HK98111099A patent/HK1010144A1/xx not_active IP Right Cessation
-
2003
- 2003-12-18 JP JP2003421386A patent/JP2004149544A/ja active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ID16420A (id) | Komposisi farmasi baru dengan efek anastesia | |
ID22074A (id) | Senyawa-senyawa baru dengan efek analgesik | |
ID21662A (id) | Senyawa-senyawa baru dengan efek analgesik | |
ID17686A (id) | Fotoinisiator alpha-aminoasetofenon baru | |
ID21881A (id) | Turunan-turunan baru pirazol tersubstitusi | |
NO985460D0 (no) | Limsammensetning | |
NO962606D0 (no) | Farmasöytisk sammensetning | |
FI944832A (fi) | Farmaseuttinen koostumus | |
ID15840A (id) | Turunan-turunan 19-nor-pregnena baru | |
ID18352A (id) | Komposisi-komposisi farmasi | |
FI955311A0 (fi) | Farmaseuttinen koostumuspohja | |
ID17774A (id) | Komposisi farmasi antitrombosis | |
ID21525A (id) | Komposisi bedak baru | |
ID24716A (id) | Formulasi baru | |
ITMI932540A0 (it) | Composizione farmaceutica | |
BR9507768A (pt) | Composição farmacêutica | |
ID29294A (id) | Komposisi farmasi | |
LV11727A (lv) | Farmaceitiska kompozicija | |
ID18698A (id) | Komposisi farmasi | |
ID18262A (id) | Turunan-turunan baru piranosida | |
ID25857A (id) | Komposisi farmasi | |
FI973280A (fi) | Farmaseuttinen koostumus | |
ID24191A (id) | Komposisi baru | |
LV10579A (lv) | Farmaceitiska kompozicija | |
ITMI962628A0 (it) | Composizione farmaceutica |